We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated System Introduced for Blood Fractionation in Biobanking Applications

By LabMedica International staff writers
Posted on 22 Jan 2013
A fully automated workstation was launched for blood fractionation in biobanking applications. More...
It effectively eliminates error-prone manual pipetting steps and increases the safety of biobanking samples with state-of-the-art imaging technology, excellent pipetting capabilities, and powerful sample tracking software.

The easyBlood STARlet workstation was introduced at the annual Society of Laboratory Automation and Screening meeting in January 2013. The system is a high-throughput, fully integrated workstation that enables technicians to reliably pipette the desired layer of primary blood samples, including the buffy coat. Compatible with laboratory information management systems (LIMS), it offers full traceability by ensuring that data can be linked confidently to each sample, and enables an efficient biobanking workflow.

The easyBlood STARlet system is manufactured by Hamilton (Bonaduz, Switzerland) and is based on the compact Hamilton Robotics Microlab STARlet platform. The Hamilton STAR line of instruments offers laboratories flexibility in liquid handling application design, including heating and cooling devices, multichannel heads, and HEPA hoods. The easyBlood STARlet workstation offers customers the ability to fractionate blood from a multitude of primary sample tubes to a variety of 2D-barcoded and storage-ready target containers found in today’s biobanks.

The comprehensive easyBlood STARlet system includes all required components and software for reading and loading barcoded, decapped samples, and additional labware such as plates and pipette tips. The instrument's high-resolution, camera-based fraction identification detects difficult targets, such as buffy coats and gel separators in centrifuged samples. The system provides complete control and monitoring of the pipetting process with software-enabled adjustment of pipetting speed to suit specific liquid classes. All three fractions (plasma, buffy coat, and erythrocytes) are pipetted and aliquoted as desired.

The easyBlood workstation also integrates with the new, -80 °C BiOS third-generation automated storage system, which was designed for sample integrity and superior service.

Related Links:
Hamilton

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
Thyroid Test
Anti-Thyroid EIA Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.